Therapeutic effect of TCA on anogenital warts

Evaluation of therapeutic effect of cryotherapy with TCA on anogenital warts

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201307153566N3

Enrollment

100

Registered

2013-08-23

Start date

2013-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anogenital wart. Anogenital (venereal) warts

Interventions

Intervention 1: Intervention grup: treatment by TCA 40% and controled every two weeks for two mouths. Intervention 2: Control grupe: treatment by cryotherapy and controled every two weeks for two moun

Treatment - Drugs

Intervention grup: treatment by TCA 40% and controled every two weeks for two mouths.

Control grupe: treatment by cryotherapy and controled every two weeks for two mounths.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with anogenital warts that their disease was detected by the clinical or pathological evidence. Exclusion criteria: patient with anogenital pathological defect and pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of warts. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.	—

Secondary

Measure	Time frame
Skin irritation. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.;Itching. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.;Fever. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.	—

Measure

Time frame

Skin irritation. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.;Itching. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.;Fever. Timepoint: The patients for eleven months and at weeks zero, one, two, three, and four, two months later, three months later, fiv months later e, seven months later, nine months later and eleven months later of treatment follow up. Method of measurement: Physical exam.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamide Azimi

Tabriz University of Medical Sciences

azimi@tbzmed.ac.ir+98 41 1540 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026